AU7501700A - Method to disrupt mitochondrial function - Google Patents
Method to disrupt mitochondrial functionInfo
- Publication number
- AU7501700A AU7501700A AU75017/00A AU7501700A AU7501700A AU 7501700 A AU7501700 A AU 7501700A AU 75017/00 A AU75017/00 A AU 75017/00A AU 7501700 A AU7501700 A AU 7501700A AU 7501700 A AU7501700 A AU 7501700A
- Authority
- AU
- Australia
- Prior art keywords
- mitochondrial function
- disrupt mitochondrial
- disrupt
- function
- mitochondrial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15657899P | 1999-09-29 | 1999-09-29 | |
US60156578 | 1999-09-29 | ||
PCT/CA2000/001130 WO2001022979A1 (en) | 1999-09-29 | 2000-09-28 | Method to disrupt mitochondrial function |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7501700A true AU7501700A (en) | 2001-04-30 |
Family
ID=22560155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75017/00A Abandoned AU7501700A (en) | 1999-09-29 | 2000-09-28 | Method to disrupt mitochondrial function |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7501700A (en) |
WO (1) | WO2001022979A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2187047T3 (en) * | 1997-08-05 | 2003-05-16 | Bioniche Life Sciences Inc | COMPOSITION AND METHOD FOR THE REGULATION OF CELL PROLIFERATION AND CELL DEATH. |
ES2238780T3 (en) * | 1998-02-18 | 2005-09-01 | Bioniche Life Sciences Inc. | TREATMENT OF BLADDER CANCER THROUGH MYCOBACTERIUM PHLEI CELL WALL. |
-
2000
- 2000-09-28 WO PCT/CA2000/001130 patent/WO2001022979A1/en active Application Filing
- 2000-09-28 AU AU75017/00A patent/AU7501700A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001022979A1 (en) | 2001-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2707399A (en) | Configuration knowledge as an aid to case retrieval | |
AU4416800A (en) | Fibre-optics | |
AU1173201A (en) | Skin-gripper | |
AU1483501A (en) | Perchlorate removal methods | |
AU4439700A (en) | Insulator | |
AU7319800A (en) | 4-oxybenzopyran derivative | |
AU2448900A (en) | Easy to remove overwrap | |
AU7453900A (en) | 4-oxybenzopyran derivative | |
AU1538901A (en) | Polymersation process | |
AU4599500A (en) | Safe | |
AU7818100A (en) | Travel safe | |
AU4535299A (en) | Improvements to traps | |
AU5120000A (en) | Structural device | |
AU7501700A (en) | Method to disrupt mitochondrial function | |
AU1386400A (en) | Extract | |
AU3809500A (en) | Expression | |
AU5552200A (en) | Method | |
AU2226599A (en) | Methods to identify myelostimulants | |
AU5287299A (en) | Safe | |
AUPP895899A0 (en) | Slitting | |
AU4585100A (en) | Method | |
AU4403100A (en) | Speech-processing system | |
AU1164401A (en) | Method | |
AUPQ403499A0 (en) | Size to fit browser | |
AU1042500A (en) | Thienooxazines as nos-inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |